Janardan Khandekar to Breast Neoplasms
This is a "connection" page, showing publications Janardan Khandekar has written about Breast Neoplasms.
Connection Strength
0.280
-
Recommendations on follow-up of breast cancer patients following primary therapy. Semin Surg Oncol. 1996 Sep-Oct; 12(5):346-51.
Score: 0.050
-
Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women's Health Initiative observational study. Breast Cancer Res Treat. 2013 Jun; 139(3):821-31.
Score: 0.040
-
Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis. 2010 Mar; 31(3):489-95.
Score: 0.031
-
Recurrence in patients on adjuvant chemotherapy for breast cancer. Cancer. 1985 Dec 01; 56(11):2736.
Score: 0.024
-
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA. 2003 Jun 25; 289(24):3243-53.
Score: 0.020
-
The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancer. J Am Coll Surg. 2001 Jul; 193(1):22-8.
Score: 0.017
-
Carcinoma in a heterotopically auto-implanted nipple. Cancer. 1979 Jun; 43(6):2502-3.
Score: 0.015
-
Endometrial carcinoma following estrogen therapy for breast cancer. Report of three cases. Arch Intern Med. 1978 Apr; 138(4):539-41.
Score: 0.014
-
Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol. 1995 Mar; 2(2):160-4.
Score: 0.011
-
Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. J Clin Oncol. 1993 Nov; 11(11):2072-80.
Score: 0.010
-
Achieving local control for inflammatory carcinoma of the breast. Surg Gynecol Obstet. 1992 Aug; 175(2):141-4.
Score: 0.009
-
Current status: evaluation of dietary fat reduction as secondary breast cancer prevention. The Nutrition Adjuvant Study. Prog Clin Biol Res. 1990; 339:201-9.
Score: 0.008
-
Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study. Cancer Treat Rep. 1984 Dec; 68(12):1511-2.
Score: 0.005
-
Phase II study of spirogermanium in advanced breast cancer. Cancer Treat Rep. 1984 Dec; 68(12):1515-6.
Score: 0.005
-
Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy. J Surg Oncol. 1984 Aug; 26(4):233-7.
Score: 0.005
-
Preoperative and follow-up procedures on patients with breast cancer. Cancer. 1980 Aug 15; 46(4 Suppl):977-9.
Score: 0.004
-
Adjuvant chemotherapy for stage II and III breast carcinoma. JAMA. 1980 Jul 18; 244(3):243-6.
Score: 0.004
-
Urinary bladder metastases from breast carcinoma. Cancer. 1980 Jul 01; 46(1):229-32.
Score: 0.004
-
Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer. 1979 Mar; 43(3):956-60.
Score: 0.004